Calliditas Therapeutics Ab Stock Price, News & Analysis
Company Description
Calliditas Therapeutics Ab (NASDAQ: CALT) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.1B, ranking #2,715 among all listed U.S. companies by market cap.
CALT stock has gained 144.2% over the past year. Shares last traded at $40.00.
This page provides a comprehensive overview of CALT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Calliditas Therapeutics Ab (CALT) stock last traded at $40.00. Over the past 12 months, the stock has gained 144.2%. At a market capitalization of $1.1B, CALT is classified as a small-cap stock with approximately 27.0M shares outstanding.
Latest News
Calliditas Therapeutics Ab has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences, clinical trial. View all CALT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CALT Company Profile & Sector Positioning
Calliditas Therapeutics Ab (CALT) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.